Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Kyverna Therapeutics, Inc. | StockGist | StockGist

Companies
KYTX
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings KYTXSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Kyverna Therapeutics, Inc.

Filed Feb 17, 2026

Accepted Feb 16, 2026, 7:00 PM ET

CIK 0001994702

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

17

Reporting Person

Kyverna Therapeutics, Inc.

Person Type

PN

CUSIP: 501976104

Amendment History

3 filings

SCHEDULE 13G
Original
Nov 17, 20250000919574-25-007080
SCHEDULE 13G/A
Amendment 1
Feb 17, 20260001193125-26-054806
SCHEDULE 13G/A
Amendment 2
Latest
Viewing
Feb 17, 20260001972690-26-000003

Key Facts

Shares Owned

17

Recent Filings

Kyverna Therapeutics, Inc.1 months ago

Kyverna Therapeutics, Inc.1 months ago

Kyverna Therapeutics, Inc.1 months ago

Kyverna Therapeutics, Inc.2 months ago

Kyverna Therapeutics, Inc.2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice